Edition:
India

Integra LifeSciences Holdings Corp (IART.OQ)

IART.OQ on NASDAQ Stock Exchange Global Select Market

51.15USD
19 Jan 2018
Change (% chg)

$0.97 (+1.93%)
Prev Close
$50.18
Open
$50.12
Day's High
$51.16
Day's Low
$50.12
Volume
102,649
Avg. Vol
199,545
52-wk High
$56.39
52-wk Low
$40.51

Select another date:

Mon, Jan 8 2018

BRIEF-Integra Lifesciences Announces Preliminary Q4 Earnings Per Share View $0.55, Revenue View $351.0

* - ‍ORGANIC REVENUE GROWTH IN Q4 IS EXPECTED TO BE ABOUT 5.5%, ABOVE COMPANY'S IMPLIED GUIDANCE OF ABOUT 4%​

BRIEF-Integra Lifesciences Holdings Corp ‍Reaffirms 2017 Financial Guidance As Provided On Oct 26, 2017​

* - ‍REAFFIRMING 2017 FINANCIAL GUIDANCE AS PROVIDED ON OCTOBER 26, 2017​

BRIEF-Capital Research Global Investors Reports 11.1 Pct Passive Stake In Integra Lifesciences As Of Nov 30

* CAPITAL RESEARCH GLOBAL INVESTORS REPORTS 11.1 PERCENT PASSIVE STAKE IN INTEGRA LIFESCIENCES HOLDINGS CORP AS OF NOVEMBER 30 - SEC FILING Source text: (http://bit.ly/2jb88l1) Further company coverage:

BRIEF-Integra Lifesciences Q3 adjusted earnings per share $0.45

* Integra Lifesciences reports third quarter 2017 financial results

BRIEF-JNJ announces completion of Codman Neurosurgery divestiture to Integra Lifesciences

* Johnson & Johnson announces completion of Codman Neurosurgery divestiture to Integra Lifesciences Holding Corporation Source text for Eikon: Further company coverage:

U.S. FTC approves Integra purchase of J&J’s Codman business

WASHINGTON Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

UPDATE 1-U.S. FTC approves Integra purchase of J&J’s Codman business

WASHINGTON, Sept 27 Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

FTC allows Integra to buy J&J’s Codman neuro business, with conditions

WASHINGTON, Sept 27 Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said on Wednesday.

BRIEF-Integra lifesciences reports preliminary assessment of damage to Puerto Rico facility

* Integra Lifesciences provides preliminary assessment of minor damage to its manufacturing facility in Añasco, Puerto Rico

BRIEF-Integra LifeSciences announces first patient enrolled in Cadence® total ankle system post-market study

* Integra LifeSciences announces first patient enrolled in Cadence® total ankle system post-market study Source text for Eikon: Further company coverage:

Select another date: